CDMO
WuXi XDC Plans $470.5M IPO to Drive Global Manufacturing Expansion
WuXi’s spinoff venture, WuXi XDC, is poised to make its debut on the Hong Kong Stock Exchange later this month, ...
EuroAPI chief Karl Rotthier resigns amid strategic review
In a swift and significant personnel decision, EuroAPI’s board of directors has announced the departure of CEO Karl Rotthier, effective ...
RLS to offer CDMO services for radiopharma at 8 US locations
The biopharmaceutical landscape is witnessing a seismic shift towards radiopharmaceuticals, with major players like Eli Lilly making substantial investments, exemplified ...
Fujifilm Irvine Scientific and Formulated Solutions announce over 50 layoffs each, according to filings
In the midst of a recent wave of workforce reductions within the biopharma sector, two contract manufacturers have implemented significant ...
EuroAPI lowers sales forecast due to CDMO challenges and inventory cuts by customers
The Contract Development and Manufacturing Organization (CDMO) sector, which experienced a surge in business during the COVID-19 pandemic, is grappling ...
QHP acquires Applied StemCell to strengthen its cell and gene therapy services for pharma clients
QHP Capital is expanding its portfolio of contract service providers by acquiring Applied StemCell (ASC), a specialized company in cell ...
Lotte Biologics to Construct 3 New Plants by 2030 After Land Purchase, Boosting Korean CDMO Capacity
Korean Contract Development and Manufacturing Organization (CDMO), Lotte Biologics, is embarking on an ambitious growth trajectory, aiming to achieve a ...
Lonza to boost ADC production capacity and hire 180 new staff
Despite the unexpected departure of Lonza’s CEO last month, the Swiss Contract Development and Manufacturing Organization (CDMO) remains a force ...
Catalent hires former Lonza bioscience chief to lead its biologics unit amid CEO departure
In a swift succession of leadership changes at Swiss contract development and manufacturing organization (CDMO) Lonza, David McErlane, the former ...
Lonza CEO Ruffieux quits after less than a year, chairman steps in
Lonza, the Swiss Contract Development and Manufacturing Organization (CDMO), is once again on the hunt for a new CEO, marking ...
What’s Behind Emergent BioSolutions’ Decision to Lay Off 400 Employees and Eliminate an Executive Role?
Emergent BioSolutions is undergoing substantial changes as it shifts its focus away from its challenged contract development and manufacturing organization ...
